NAD+: a metabolic knob fine-tuning inflammation during senescence

The senescence-associated secretory phenotype (SASP) is responsible for the deleterious effects of senescent cells in ageing and cancer. A new study shows that NAD+ metabolism can regulate the pro-inflammatory SASP, thereby promoting tumorigenesis.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: NAD+ metabolism regulates the pro-inflammatory SASP and can promote tumour progression.


  1. 1.

    Herranz, N. & Gil, J. J. Clin. Invest. 128, 1238–1246 (2018).

    Article  Google Scholar 

  2. 2.

    Georgilis, A. et al. Cancer Cell 34, 85–102.e109 (2018).

    CAS  Article  Google Scholar 

  3. 3.

    Nacarelli, T. et al. Nat. Cell Biol. (2019).

  4. 4.

    Narita, M. et al. Cell 126, 503–514 (2006).

    CAS  Article  Google Scholar 

  5. 5.

    Garten, A. et al. Nat. Rev. Endocrinol. 11, 535–546 (2015).

    CAS  Article  Google Scholar 

  6. 6.

    Rielland, M. et al. J. Clin. Invest. 124, 2125–2135 (2014).

    CAS  Article  Google Scholar 

  7. 7.

    Kaplon, J. et al. Nature 498, 109–112 (2013).

    CAS  Article  Google Scholar 

  8. 8.

    Rajman, L., Chwalek, K. & Sinclair, D. A. Cell Metab. 27, 529–547 (2018).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Jesús Gil.

Ethics declarations

Competing interests

J.G. owns equity in and is a consultant for Unity Biotechnology. Unity Biotechnology funds research on senolytics in the laboratory of J.G. J.G is a named inventor in a filed MRC patent related to senolytic therapies (PCT/GB2018/051437) that has been licensed to Unity Biotechnology.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Søgaard, P.P., Gil, J. NAD+: a metabolic knob fine-tuning inflammation during senescence. Nat Metab 1, 310–311 (2019).

Download citation

Further reading